ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
HeyLine
|
22K |
7.9M |
17 |
20/09/24 |
20/09/24 |
ASX - By Stock
|
22K
|
7.9M
|
17
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
HeyLine
|
22K |
7.9M |
1 |
20/09/24 |
20/09/24 |
ASX - By Stock
|
22K
|
7.9M
|
1
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
HeyLine
|
22K |
7.9M |
7 |
20/09/24 |
20/09/24 |
ASX - By Stock
|
22K
|
7.9M
|
7
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
HeyLine
|
22K |
7.9M |
6 |
20/09/24 |
20/09/24 |
ASX - By Stock
|
22K
|
7.9M
|
6
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
HeyLine
|
22K |
7.9M |
7 |
20/09/24 |
20/09/24 |
ASX - By Stock
|
22K
|
7.9M
|
7
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
HeyLine
|
22K |
7.9M |
5 |
20/09/24 |
20/09/24 |
ASX - By Stock
|
22K
|
7.9M
|
5
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
HeyLine
|
22K |
7.9M |
8 |
20/09/24 |
20/09/24 |
ASX - By Stock
|
22K
|
7.9M
|
8
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
HeyLine
|
307 |
96K |
6 |
19/09/24 |
19/09/24 |
ASX - By Stock
|
307
|
96K
|
6
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
HeyLine
|
22K |
7.9M |
2 |
17/09/24 |
17/09/24 |
ASX - By Stock
|
22K
|
7.9M
|
2
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
HeyLine
|
22K |
7.9M |
2 |
17/09/24 |
17/09/24 |
ASX - By Stock
|
22K
|
7.9M
|
2
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
HeyLine
|
307 |
96K |
10 |
16/09/24 |
16/09/24 |
ASX - By Stock
|
307
|
96K
|
10
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
HeyLine
|
307 |
96K |
7 |
16/09/24 |
16/09/24 |
ASX - By Stock
|
307
|
96K
|
7
|
|
ASX - By Stock
|
BGD |
Re:
bgd chart
|
|
HeyLine
|
53 |
19K |
3 |
14/09/24 |
14/09/24 |
ASX - By Stock
|
53
|
19K
|
3
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
HeyLine
|
22K |
7.9M |
2 |
14/09/24 |
14/09/24 |
ASX - By Stock
|
22K
|
7.9M
|
2
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
HeyLine
|
22K |
7.9M |
20 |
14/09/24 |
14/09/24 |
ASX - By Stock
|
22K
|
7.9M
|
20
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
HeyLine
|
307 |
96K |
8 |
14/09/24 |
14/09/24 |
ASX - By Stock
|
307
|
96K
|
8
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
HeyLine
|
307 |
96K |
8 |
14/09/24 |
14/09/24 |
ASX - By Stock
|
307
|
96K
|
8
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
HeyLine
|
307 |
96K |
16 |
14/09/24 |
14/09/24 |
ASX - By Stock
|
307
|
96K
|
16
|
|
Charts
|
CHN |
Re:
CHN chart
|
|
HeyLine
|
9.2K |
4.1M |
1 |
13/09/24 |
13/09/24 |
Charts
|
9.2K
|
4.1M
|
1
|
|
Charts
|
CHN |
Re:
CHN chart
|
|
HeyLine
|
9.2K |
4.1M |
12 |
13/09/24 |
13/09/24 |
Charts
|
9.2K
|
4.1M
|
12
|
|
ASX - By Stock
|
USL |
Re:
USL Chart Thread
|
|
HeyLine
|
121 |
45K |
3 |
13/09/24 |
13/09/24 |
ASX - By Stock
|
121
|
45K
|
3
|
|
ASX - By Stock
|
USL |
Re:
USL Chart Thread
|
|
HeyLine
|
121 |
45K |
9 |
13/09/24 |
13/09/24 |
ASX - By Stock
|
121
|
45K
|
9
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
HeyLine
|
22K |
7.9M |
2 |
12/09/24 |
12/09/24 |
ASX - By Stock
|
22K
|
7.9M
|
2
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
HeyLine
|
22K |
7.9M |
0 |
12/09/24 |
12/09/24 |
ASX - By Stock
|
22K
|
7.9M
|
0
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
HeyLine
|
22K |
7.9M |
12 |
11/09/24 |
11/09/24 |
ASX - By Stock
|
22K
|
7.9M
|
12
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
HeyLine
|
2.4K |
800K |
3 |
11/09/24 |
11/09/24 |
ASX - By Stock
|
2.4K
|
800K
|
3
|
|
ASX - By Stock
|
BGD |
Re:
Ann: High Grade Assays Confirm New Tolmer Gold System
|
|
HeyLine
|
12 |
4.7K |
1 |
11/09/24 |
11/09/24 |
ASX - By Stock
|
12
|
4.7K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
HeyLine
|
307 |
96K |
34 |
10/09/24 |
10/09/24 |
ASX - By Stock
|
307
|
96K
|
34
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
HeyLine
|
11K |
4.1M |
7 |
10/09/24 |
10/09/24 |
General
|
11K
|
4.1M
|
7
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
HeyLine
|
22K |
7.9M |
4 |
09/09/24 |
09/09/24 |
ASX - By Stock
|
22K
|
7.9M
|
4
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
HeyLine
|
11K |
4.1M |
8 |
09/09/24 |
09/09/24 |
General
|
11K
|
4.1M
|
8
|
|
ASX - By Stock
|
CHN |
Re:
Ann: Presentation - Resources Rising Stars Conference
|
|
HeyLine
|
15 |
8.7K |
3 |
09/09/24 |
09/09/24 |
ASX - By Stock
|
15
|
8.7K
|
3
|
|
ASX - By Stock
|
USL |
Re:
Ann: Acquisition of Joaquin Silver District
|
|
HeyLine
|
61 |
22K |
5 |
08/09/24 |
08/09/24 |
ASX - By Stock
|
61
|
22K
|
5
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
HeyLine
|
22K |
7.9M |
3 |
07/09/24 |
07/09/24 |
ASX - By Stock
|
22K
|
7.9M
|
3
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
HeyLine
|
22K |
7.9M |
6 |
07/09/24 |
07/09/24 |
ASX - By Stock
|
22K
|
7.9M
|
6
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
HeyLine
|
22K |
7.9M |
1 |
06/09/24 |
06/09/24 |
ASX - By Stock
|
22K
|
7.9M
|
1
|
|
ASX - By Stock
|
USL |
Re:
Ann: Acquisition of Joaquin Silver District
|
|
HeyLine
|
61 |
22K |
4 |
06/09/24 |
06/09/24 |
ASX - By Stock
|
61
|
22K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Speculative M&A Transaction Analysis
|
|
HeyLine
|
854 |
315K |
1 |
06/09/24 |
06/09/24 |
ASX - By Stock
|
854
|
315K
|
1
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
HeyLine
|
22K |
7.9M |
0 |
06/09/24 |
06/09/24 |
ASX - By Stock
|
22K
|
7.9M
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Speculative M&A Transaction Analysis
|
|
HeyLine
|
854 |
315K |
12 |
06/09/24 |
06/09/24 |
ASX - By Stock
|
854
|
315K
|
12
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
HeyLine
|
307 |
96K |
14 |
05/09/24 |
05/09/24 |
ASX - By Stock
|
307
|
96K
|
14
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
HeyLine
|
3.0K |
1.0M |
13 |
05/09/24 |
05/09/24 |
ASX - By Stock
|
3.0K
|
1.0M
|
13
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
HeyLine
|
22K |
7.9M |
2 |
04/09/24 |
04/09/24 |
ASX - By Stock
|
22K
|
7.9M
|
2
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
HeyLine
|
22K |
7.9M |
0 |
04/09/24 |
04/09/24 |
ASX - By Stock
|
22K
|
7.9M
|
0
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
HeyLine
|
2.2K |
782K |
51 |
03/09/24 |
03/09/24 |
ASX - By Stock
|
2.2K
|
782K
|
51
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Oncology Board Renewal Update
|
|
HeyLine
|
108 |
32K |
28 |
02/09/24 |
02/09/24 |
ASX - By Stock
|
108
|
32K
|
28
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Oncology Board Renewal Update
|
|
HeyLine
|
108 |
32K |
38 |
02/09/24 |
02/09/24 |
ASX - By Stock
|
108
|
32K
|
38
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Oncology Board Renewal Update
|
|
HeyLine
|
108 |
32K |
23 |
02/09/24 |
02/09/24 |
ASX - By Stock
|
108
|
32K
|
23
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Oncology Board Renewal Update
|
|
HeyLine
|
108 |
32K |
6 |
02/09/24 |
02/09/24 |
ASX - By Stock
|
108
|
32K
|
6
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Oncology Board Renewal Update
|
|
HeyLine
|
108 |
32K |
32 |
02/09/24 |
02/09/24 |
ASX - By Stock
|
108
|
32K
|
32
|
|